PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea flag South Korea · Delayed Price · Currency is KRW
322,000
-3,000 (-0.92%)
Apr 29, 2026, 3:30 PM KST

PharmaResearch Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
165,12192,04376,55140,57746,689
Upgrade
Depreciation & Amortization
15,81513,64511,99610,6029,552
Upgrade
Loss (Gain) From Sale of Assets
162.1411.92-36.115,846-229.6
Upgrade
Asset Writedown & Restructuring Costs
1,394-3,120-839.66
Upgrade
Loss (Gain) From Sale of Investments
-1,72920,191-3,0422,259-943.49
Upgrade
Loss (Gain) on Equity Investments
-425.47-5,954-680.032,192-556.93
Upgrade
Stock-Based Compensation
149.42658.9657.1505.88-
Upgrade
Provision & Write-off of Bad Debts
452.14-244.35582.21290.45-406.73
Upgrade
Other Operating Activities
26,87917,3856,5127,5981,932
Upgrade
Change in Accounts Receivable
-4,445-8,535717.13-4,843-3,842
Upgrade
Change in Inventory
-26,249-11,940-28,188-8,3742,927
Upgrade
Change in Accounts Payable
169.167,724-559.07597.78397.75
Upgrade
Change in Unearned Revenue
-7.9472.116.3211.36-
Upgrade
Change in Income Taxes
---9.631.52
Upgrade
Change in Other Net Operating Assets
5,87613,063-3,2302,1319,088
Upgrade
Operating Cash Flow
183,162138,12264,94559,40465,297
Upgrade
Operating Cash Flow Growth
32.61%112.67%9.33%-9.03%101.59%
Upgrade
Capital Expenditures
-29,727-36,415-12,063-17,257-20,645
Upgrade
Sale of Property, Plant & Equipment
179.730.6828.65734.02-
Upgrade
Cash Acquisitions
----35.01-
Upgrade
Sale (Purchase) of Intangibles
-4,877-2,310-623.05-460.83-2,786
Upgrade
Investment in Securities
-125,081-179,213-31,8605,446-66,427
Upgrade
Other Investing Activities
-82.432,507-522.63-794.6-590.91
Upgrade
Investing Cash Flow
-155,918-225,538-44,668-11,908-93,755
Upgrade
Long-Term Debt Issued
-10,782--50,000
Upgrade
Total Debt Issued
-10,782--50,000
Upgrade
Short-Term Debt Repaid
----860-29.13
Upgrade
Long-Term Debt Repaid
-3,370-17,946-18,799-2,126-1,976
Upgrade
Total Debt Repaid
-3,370-17,946-18,799-2,986-2,005
Upgrade
Net Debt Issued (Repaid)
-3,370-7,164-18,799-2,98647,995
Upgrade
Issuance of Common Stock
--359.24--
Upgrade
Dividends Paid
-11,729-10,090-7,529-6,316-5,030
Upgrade
Other Financing Activities
-174-102.45-0--0
Upgrade
Financing Cash Flow
-15,273182,643-25,969-9,30142,965
Upgrade
Foreign Exchange Rate Adjustments
-1,6571,1184.41-76.12300.33
Upgrade
Miscellaneous Cash Flow Adjustments
-01,7580-6,862151.51
Upgrade
Net Cash Flow
10,31598,103-5,68731,25714,959
Upgrade
Free Cash Flow
153,435101,70752,88342,14744,652
Upgrade
Free Cash Flow Growth
50.86%92.33%25.47%-5.61%-
Upgrade
Free Cash Flow Margin
28.61%29.05%20.26%21.64%28.98%
Upgrade
Free Cash Flow Per Share
13266.869879.605008.314224.854441.83
Upgrade
Cash Interest Paid
2,182428.67493.61159.45196.15
Upgrade
Cash Income Tax Paid
39,61619,81116,96213,79810,051
Upgrade
Levered Free Cash Flow
109,27067,22521,15325,11527,225
Upgrade
Unlevered Free Cash Flow
115,76570,12123,02027,50928,046
Upgrade
Change in Working Capital
-24,657384.04-30,714-10,4678,421
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.